Language selection

Search

2009-10-14 - Male - 11 Years old

331512

Adverse reaction report number 331512
Latest AER version number 0
Market authorization holder AER number SPV1200901974
Initial received date 2009-10-14
Latest received date 2009-10-14
Age 11 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization Yes
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectUnknown15 Milligram Attention deficit/hyperactivity disorder
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectUnknown10 Milligram1 every 1 Day(s)2 Year(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Eye pruritus
Lacrimation increased
Date modified: